Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,787.00
Bid: 1,786.50
Ask: 1,787.00
Change: 9.00 (0.51%)
Spread: 0.50 (0.028%)
Open: 1,780.00
High: 1,793.50
Low: 1,766.50
Prev. Close: 1,778.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Footsie advances as Barclays rebounds

Mon, 02nd Jul 2012 11:41

- Better-than-expected manufacturing data from Asia- Eurozone jobless rate at all-time high- UK manufacturing PMI beats forecastsLondon's blue-chip index held on to gains on Monday morning with Barclays leading the risers as it continues to rebound after last week's sharp falls.Economic data from Asia helped to lift sentiment early on: China's purchasing managers' index (PMI) fell from 50.4 to 50.2 last month, according to the National Bureau of Statistics and China Federation of Logistics and Purchasing, beating forecasts of around 49.9; while Japan's Tankan manufacturers' sentiment survey improved from minus four to minus one in the second quarter, compared to expectations of an unchanged reading. The Eurozone's unemployment rate rose to 11.1% in May, in line with estimates and the highest since the creation of the Eurozone, according to the latest data from the region's statistics office, Eurostat. In domestic news, UK manufacturing PMI rose from 45.9 to 48.6 in June, well ahead of expectations of 46.5. However, with the sector still contracting (readings below 50 points), the pressure is mounting for the Bank of England to ramp up its asset purchase programme on Thursday when it announces its July policy decision.FTSE 100: Barclays rebounds after recent sell-offBarclays, the bank which last week was given a £290m fine for manipulating interbank lending rates, was a high riser today after revealing that its Chairman Macrus Agius has resigned. After numerous calls for CEO Bob Diamond to follow in Agius's footsteps, Investec analyst Ian Gordon said this morning that investors should "back Bob" and take advantage of the stock's recent underperformance.Royal Bank of Scotland (RBS) was flat after Oriel Securities downgraded its rating on the stock to 'hold'. It was revealed at the weekend that the bank had sacked several traders last year over the alleged manipulation of LIBOR. Insurance group Aviva advanced after announcing that Lord Colin Sharman has retired as Chairman and has been replaced by John McFarlane.Pharmaceuticals giant GlaxoSmithKline rose after revealing positive results from four pivotal phase III studies for its once-daily COPD treatment. The company said that the results of the studies support its intention to commence global regulatory submissions for the treatment from the end of 2012. Sector peer AstraZeneca was flat despite saying that Bristol-Myers Squibb's acquisition of Amylin Pharmaceuticals will strengthen the leadership position of its diabetes alliance with Bristol-Myers in a "growing area of high unmet medical need". Astra will make a payment of $3.4bn in cash to Amylin once it becomes a wholly-owned subsidiary of Bristol-Myers. Serco, the international services company, rose after it signed an agreement to dispose of most of its operations in Germany in a transaction with the local management team. FTSE 250: SOCO jumps over 8%Oil and gas group SOCO International surged after entering into a 'conditional' agreement with Lizeroux Oil & Gas to acquire the 20% minority interest in SOCO Vietnam that the group does not already own. Insurance group Catlin fell after Jefferies downgraded the stock as part of its review into the European insurance industry: "With Catlin now close to our price target, we downgrade to 'hold' also noting higher end US windstorm exposure and a broadly untouched reinsurance deductible." FTSE 100 - RisersBarclays (BARC) 168.65p +3.56%Aviva (AV.) 281.90p +3.41%Petrofac Ltd. (PFC) 1,427.00p +2.81%Weir Group (WEIR) 1,571.00p +2.68%Whitbread (WTB) 2,071.00p +2.12%BP (BP.) 430.05p +1.92%Rio Tinto (RIO) 3,077.00p +1.92%Amec (AMEC) 1,021.00p +1.90%Prudential (PRU) 751.00p +1.76%WPP (WPP) 786.50p +1.75%FTSE 100 - FallersShire Plc (SHP) 1,782.00p -2.73%British Sky Broadcasting Group (BSY) 688.00p -1.22%Smith & Nephew (SN.) 630.00p -1.18%Vodafone Group (VOD) 177.45p -1.00%Admiral Group (ADM) 1,183.00p -0.76%Morrison (Wm) Supermarkets (MRW) 264.40p -0.64%Pearson (PSON) 1,259.00p -0.55%AstraZeneca (AZN) 2,838.00p -0.53%Next (NXT) 3,184.00p -0.47%Capital Shopping Centres Group (CSCG) 320.90p -0.34%FTSE 250 - RisersSoco International (SIA) 310.90p +7.43%Imagination Technologies Group (IMG) 499.50p +7.05%Fenner (FENR) 380.80p +5.40%Aquarius Platinum Ltd. (AQP) 48.11p +5.37%Kenmare Resources (KMR) 41.50p +5.06%Travis Perkins (TPK) 1,019.00p +5.00%Ashtead Group (AHT) 271.40p +4.42%Shanks Group (SKS) 79.25p +3.80%Smith (DS) (SMDS) 152.70p +3.60%Oxford Instruments (OXIG) 1,269.00p +3.42%FTSE 250 - FallersAvocet Mining (AVM) 81.00p -10.05%Ocado Group (OCDO) 75.40p -2.96%Halfords Group (HFD) 223.60p -2.44%Euromoney Institutional Investor (ERM) 731.00p -2.08%Spirit Pub Company (SPRT) 49.75p -1.97%Debenhams (DEB) 85.25p -1.45%Catlin Group Ltd. (CGL) 419.80p -1.34%Perform Group (PER) 395.00p -1.25%Ruspetro (RPO) 133.50p -1.18%Home Retail Group (HOME) 83.65p -1.18%FTSE TechMARK - RisersAsterand (ATD) 1.05p +13.51%Phytopharm (PYM) 6.20p +5.53%Timeweave (TMW) 21.00p +5.00%Hiwave Technologies (HIW) 1.50p +3.45%Gresham Computing (GHT) 61.00p +2.95%Electronic Data Processing (EDP) 43.50p +2.35%Oxford Biomedica (OXB) 2.40p +2.13%Kofax (KFX) 256.25p +2.09%NCC Group (NCC) 815.00p +2.07%Sepura (SEPU) 68.25p +1.87%FTSE TechMARK - FallersBATM Advanced Communications Ltd. (BVC) 14.00p -4.27%Emblaze Ltd. (BLZ) 51.60p -3.55%AEA Technology Group (AAT) 0.20p -2.44%Vectura Group (VEC) 76.00p -0.98%Skyepharma (SKP) 78.25p -0.95%Phoenix IT Group (PNX) 180.00p -0.83%Microgen (MCGN) 139.00p -0.71%Ricardo (RCDO) 340.00p -0.58%Psion (PON) 87.00p -0.57%Consort Medical (CSRT) 700.00p -0.57%
More News
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.